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Abstract In the presence of assembled K-hemolysin (K-HL) of
Staphylococcus aureus, the epidermal growth factor receptor
(EGFr) is rapidly dephosphorylated. Several obvious possibil-
ities that otherwise would have contributed to the dephosphor-
ylation were ruled out. Instead, an elevation in the activity of a
protein tyrosine phosphatase appears to be responsible for the
observed loss of phosphorylation signal of EGFr. For this de-
phosphorylation, the assembly of K-HL is necessary while lytic
pore formation is not required. In summary, the EGFr is unable
to retain its phosphorylation signal in the presence of K-HL and
the process is irreversible.
$ 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The transmembrane pores formed by K-hemolysin (K-HL)
of Staphylococcus aureus trigger several pathophysiologically
important secondary cellular reactions [1^4]. In essence, the
action of this toxin on nucleated cells may be diverse and
more complex than on red blood cells. In case of susceptible
cells, the K-HL has been shown to insert the amino acid re-
gion 118^140 into the membrane bilayer to form lytic oligo-
mer, whereas resistant cells can prevent such an insertion [5].
Despite these insights, the mechanism by which K-HL acts on
nucleated cells for example on dermal cells is not clear (K-HL
has been attributed dermonecrotic property). In other words,
what are the events that occur immediately after the binding
of K-HL? Can K-HL disrupt the signal transduction cascades
of the cell? It is generally assumed that K-HL being a pore
forming toxin, can simply deplete a cell of its essential ingre-
dients leading to its death. Lazarovici and Chan had ob-
served, in PC12 cells upon treatment with K-HL, a decrease
in the a⁄nity of the epidermal growth factor receptor (EGFr)
for epidermal growth factor [6]. The pathway of action of
K-HL has remained, however, unexplained. Considering the in-
volvement of S. aureus in pathogenesis in humans, it is essen-
tial to carry out an in depth study in order to understand the
early events that occur when K-HL acts on EGFr containing
cells. Such a study can help us understand the molecules that
mediate or act in synergy to regulate the EGFr function [7^
10]. With this aim, we have investigated the mechanism of
action of K-HL based on its structure, assembly and function
using the A431 epidermoid carcinoma cell line [21]. Our data
provides an important clue regarding the role of a protein
tyrosine phosphatase (PTPase) which can dephosphorylate
the EGFr in the presence of K-HL.
2. Materials and methods
All the reagents used were of analytical grade and all experiments
described here were carried out independently at least three times.
Transforming growth factor K (TGFK) and in vitro transcription
and translation kit were obtained from Promega, Madison, WI,
USA. Fetal calf serum (FCS) was purchased from Harlan, Sera
Lab. RPMI, anti-phosphotyrosine antibody 6G9 and anti-EGF recep-
tor antibody (sheep polyclonal) were obtained from Gibco BRL.
Horseradish peroxidase (HRP) conjugated anti-phosphotyrosine anti-
body (PY20^HRP) and anti-EGFr antibodies (SC-120 and SC-03
were respectively used for immuno precipitation and immunodetec-
tion) were from Santa Cruz Biotech, Santa Cruz, CA, USA. HRP
conjugated anti-mouse antibody and chemiluminescence detection
kit were purchased from New England Bio-Labs.
2.1. Puri¢cation of K-HL, K-HL(5^293) and H35N
The mature form of K-HL is a 293 amino acid long (A1-D-S-D-ITE-
E-M-T-N293) protein [11]. K-HL(5^293) is an amino terminal deletion
mutant of K-HL lacking the ¢rst four amino acids (A1-D-S-D4) which
assembles into the heptameric pores like K-HL [11]. The H35N mu-
tant of K-HL (histidine-35 of K-HL is replaced with aspargine) was
constructed as described earlier [12]. K-HL, K-HL(5^293) and H35N
were cloned and expressed in E. coli (JM109(DE3) or BL21(DE3))
under control of T7 promoter. [35S]Methionine labeling of K-HL,
K-HL(5^293) and H35N was achieved by coupled in vitro transcrip-
tion and translation using the super coiled plasmids as described ear-
lier [11^13].
2.2. Cell culture
A431 cells were cultured in RPMI medium bu¡ered with 2.5 mM
N-(2-hydroxyethyl)piperazine-NP-2-ethanesulfonate (HEPES) supple-
mented with 5% FCS and antibiotics (streptomycin sulfate and pen-
icillin G). Cells at approximately 70^80% con£uency were trypsinized
with 10^50 Wg/ml trypsin. The cells were starved in a serum free
medium for a minimum of 10^12 h before the experiment. We have
not observed any degraded EGFr fragments of low molecular weight
which could have arisen due to the mild trypsinization, as judged by
immunodetection of EGFr. This is consistent with the observations of
Chinkers and Brugge as the extracellular portion of EGFr has no
susceptible loci for trypsin [14]. In addition, experiments were also
performed by dislodging the monolayer with phosphate bu¡ered sa-
line (PBS) containing 1 mM EDTA (without trypsin) and the dephos-
phorylation e¡ect induced by K-HL was consistently observed.
2.3. Binding and oligomerization on A431 cells
The A431 cells were incubated with 3 Wl of the [35S]methionine
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labeled K-HL or K-HL(5^293) (3 Wl) or H35N (12 Wl), in a total
volume of 33 Wl at 37‡C. Aliquots of cells (11 Wl ; 4U104) were taken
out at 2, 5 and 15 min and the cell pellet was washed once with
Dulbecco’s PBS (D-PBS). This was followed by addition of
1ULaemmli’s sample bu¡er (LSB; 25 Wl). The samples were heated
at 60‡C for 10 min and electrophoresed on 9% sodium dodecyl sul-
fate^polyacrylamide gel electrophoresis (SDS^PAGE) according to
the method of Laemmli [15]. The resultant gel was dried and kept
for autoradiography.
2.4. Assay for phosphorylation of EGFr using anti-phosphotyrosine
antibody
A431 cells (2.0U105) were incubated with an indicated amount of
the toxin in a total volume of 50 Wl at 37‡C for indicated time periods.
The cells were washed once with D-PBS to remove the unbound toxin
and ¢nally resuspended in 50 Wl of D-PBS. The cells were stimulated
at 37‡C for 10 min with TGFK (20 ng; 66 nM). The cell pellet was
recovered by centrifugation, resuspended in LSB (20 Wl) containing
protease inhibitors (10 Wg/ml leupeptin, 2 mM phenylmethylsulfonyl
£uoride (PMSF) and 2 mM Na3VO4, boiled for 10 min and electro-
phoresed on 7% SDS^PAGE after centrifugation. The proteins were
transferred to a nitrocellulose membrane using 10 mM 3-[cyclohexy-
lamino]-1-propanesulfonic acid bu¡er (pH 10.5) at 250 mA for 2 h.
The blot was subjected to immuno detection with anti-phosphotyro-
sine antibody. The cells treated with TGFK exhibited a slightly di¡use
EGFr band as a result of its phosphorylation [16]. For the experi-
ments in the presence of tyrosine phosphatase inhibitors, an identical
protocol was followed with the exception that the A431 cells
(2.0U105) were preincubated in D-PBS containing 50 WM Na3VO4
and 50 WM NaF at 37‡C for 30 min and the phosphatase inhibitors
were maintained throughout the course of experiment. In the experi-
ments with prestimulated cells, the cells were ¢rst treated with 66 nM
TGFK followed by treatment with K-HL. The rest of the protocol was
the same as described above. Binding, oligomerization and phosphor-
ylation assays on other cells lines were essentially similar to those
carried out on A431 cells.
2.5. Quantitation of phosphorylation
The bands obtained after immunodetection with anti-phosphotyro-
sine antibody or with anti-EGFr antibody were quanti¢ed by scan-
ning using a Bio-Rad phosphor-imager software. The band intensity
of TGFK stimulated cells was taken as 100% and the intensity of
other bands was expressed as percent of TGFK stimulated lanes.
2.6. ATP release assays
The ATP released in response to the binding of K-HL was assayed
by ATP Bioluminescence kit (Boehringer-Mannheim). For these ex-
periments, 3U105 cells were suspended in medium without FCS and
were incubated with or without K-HL (50 nM) for di¡erent time
periods. The cells were pelleted and the amount of ATP released
into the medium was measured by adding 50 Wl of the biolumines-
cence reagent to 50 Wl supernatant. The light intensity was measured
by using a Perkin-Elmer LS 50B spectro£uorimeter operating in lu-
minescence mode at 550 nm. For measuring the intracellular ATP, the
cells were lysed with 50 Wl of 0.5% Triton X-100, centrifuged at
10 000Ug for 1 min and the ATP content present in the supernatant
was measured.
2.7. Assay for receptor dimers
The A431 cells (1U106) were incubated with indicated amount of
K-HL for 30 min at 37‡C in a total volume of 50 Wl. The cells were
washed, resuspended in 46 Wl of D-PBS, stimulated with 40 ng (4 Wl,
130 nM) TGFK followed by incubation at 37‡C for 30 min. The
volume was made up to 190 Wl with D-PBS. Glutaraldehyde (10 Wl)
was added to a ¢nal concentration of 500 WM. The cross-linking
reaction was allowed to proceed for 1 min at room temperature and
the reaction was quenched by the addition of glycine (pH 9.0) to a
¢nal concentration of 5 mM. After an additional 10 min, the cells
were centrifuged and lysed in lysis bu¡er (50 mM HEPES, 0.5%
Triton X-100, 10% glycerol, 1.5 mM MgCl2, 1.0 mM EDTA, 3.0
mM MnCl2, 2.0 mM Na3VO4, 10 Wg/ml leupeptin, 2 mM PMSF)
on ice for 1 h. The lysate was clari¢ed at 10 000 rpm for 10 min
and supernatant was precipitated with 8 volumes of prechilled acetone
at 370‡C. The precipitate was collected by centrifugation, dried and
solubilized in 1ULSB, boiled for 10 min, and electrophoresed on 5%
SDS^PAGE. The proteins were transferred onto nitrocellulose mem-
brane at 250 mA for 2.5 h as described above. The blot was probed
with an anti-phosphotyrosine antibody.
3. Results and discussion
Among the toxins secreted by S. aureus, K-HL is a 293
amino acid long monomer which has excellent solubility in
extracellular medium. This monomeric form, also known as
the ‘water soluble’ form, e⁄ciently assembles into heptameric
pores on target cell membranes. During this pore formation,
the water soluble monomeric K-HL (stage 1) binds to target
cell membranes as a monomer (or protomer). This cell bound
monomer (stage 2) interacts with other such monomers to
form a non-lytic, pre-pore (stage 3). This pre-pore undergoes
further conformational changes to form a lytic pore or trans-
membrane channel (stage 4). The carboxy terminal deletion
mutants of K-HL (deletion of two to four amino acids) are
unable to fold properly and hence lack e⁄cient inter protomer
interactions to form the non-lytic, pre-pore (i.e. are unable to
assemble beyond stage 2). In contrast, the amino terminal
deletion mutants (two to four amino acid deletions) were
found to be arrested at stage 3 as non-lytic pre-pores [11^
13,17]. Only the full length K-HL is able to form the lytic
pore e⁄ciently (stage 4). In addition, the histidine-35 of
K-HL is essential for oligomerization of the toxin. Although
H35N folds much like the water soluble form of K-HL, it
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Fig. 1. Binding and oligomerization of K-HL, K-HL(5^293) and H35N on A431 cells: [35S]Met labeled K-HL, K-HL(5^293) and H35N were in-
cubated with A431 cells, the unbound toxin was removed by centrifugation and the cell lysate was subjected to 7% SDS^PAGE. Four fold
higher amounts of [35S]methionine labeled H35N was employed to detect even the weaker oligomeric band of H35N, if at all present. The
bands O7 and M1 represent the heptameric oligomer (V200 kDa) and respective monomers of K-HL (33 kDa). The oligomer bands (O7) were
further authenticated by reelectrophoresis after extraction from un¢xed, dried gels as described earlier [11].
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cannot assemble beyond stage 2. Theoretically, when K-HL
binds to target cells, all the three forms viz. the cell bound
monomer (stage 2), non-lytic pre-pore (stage 3) and lytic pore
(stage 4) can be present on the target cell membrane as only a
fraction of the bound K-HL undergoes all the conformational
changes to form the lytic pore. In the present study we have
examined all these forms (stages 1 to 4) in detail in order to
¢nd out which form is responsible for its e¡ect on EGFr of
A431 cells. We have exclusively focused our attention on the
EGFr phosphorylation because in this event the receptor ty-
rosine kinase of EGFr, ligand (in the present study it is
TGFK), ATP and a phosphatase(s) are believed to be in a
dynamic equilibrium. Any change in the status of EGFr phos-
phorylation can be correlated to the assembly state of K-HL
present on the cell surface.
The data in Fig. 1 clearly shows that the K-HL and
K-HL(5^293) bind to and oligomerize on A431 cells as e⁄-
ciently as they do on rRBCs. The H35N, as expected, bound
the A431 cells but did not oligomerize. In Fig. 2, the e¡ect of
K-HL on the phosphorylation of EGFr is shown. A complete
loss of phosphorylation of EGFr was observed with the K-HL
concentrations as low as 6.0 nM (Fig. 2A) in 1 h as compared
to the cells stimulated with TGFK alone. This e¡ect of K-HL
on EGFr phosphorylation was seen within 2^10 min of treat-
ment (Fig. 2B). Also, dimeric forms of EGFr exhibited total
loss of phosphorylation signal (Fig. 2C).
The absence of autophosphorylation activity of EGFr in
the presence of a pore forming toxin can be due to any one
or more of the following possibilities: (i) Depletion of intra-
cellular ATP can occur due to pore formation. Such a deple-
tion of intracellular ATP pool has been shown to down reg-
ulate the phosphorylation signal of the EGFr [18]. (ii) Rapid
down regulation of the EGFr due to the presence of K-HL,
which might result in the inaccessibility of EGFr to TGFK.
(iii) Shedding of the receptors due to activation of certain
membrane bound proteases. (iv) Perturbation of equilibrium
of molecular interactions occurring at the membrane with an
e¡ect on EGFr phosphorylation by K-HL. All these possibil-
ities were explored to unravel the mechanism of action of
K-HL below.
3.1. Assembly of K-HL is important for the e¡ect
Our earlier studies have shown that the K-HL(5^293) exhib-
its a signi¢cantly retarded cell lysis in case of rabbit red blood
cells [11]. We therefore anticipated that it would take a much
longer time for K-HL(5^293) to diminish phosphorylation of
the EGFr. Interestingly enough, the experiments with
K-HL(5^293) showed a total absence of phosphorylation sig-
nal of EGFr in the same time range, 2^15 min, as observed
for K-HL (Fig. 3A). However, both K-HL and K-HL(5^293)
oligomerize on A431 cells as fast as they do on rRBCs. These
observations strongly suggest that lytic pore formation and/or
membrane damage do not underlie the observed absence of
phosphorylation of EGFr. Thus, it is likely that a well de¢ned
assembly of the toxin into heptamers may be necessary to
cause the loss of phosphorylation of EGFr as both K-HL
and K-HL(5^293) exhibited about the same kinetics (Fig. 3B).
There is a ‘lag period’ in the assembly of K-HL between
stages 2 and 4 [1,11^13]. The lysis of cells begins to occur as
the pre-pore (stage 3) converts itself to a lytic pore (stage 4).
The lag period for K-HL is in the order of several minutes and
is further dependent on the toxin concentration and cell type
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Fig. 2. Diminished phosphorylation of EGFr induced by K-HL at
di¡erent concentrations and time points. A: Concentration depen-
dence: A431 cells after K-HL treatment were processed as described
in Section 2. Throughout the manuscript, the lanes designated as
control and TGFK refer to mock treated A431 cells and cells stimu-
lated with TGFK (66 nM) respectively. The phosphorylation pattern
was identi¢ed by 6G9 anti-phosphotyrosine antibody and the EGFr
band was detected by anti-EGFr (sheep polyclonal). The mean den-
sity of all EGFr bands present in the bottom panel by taking the
TGFK stimulated lane as 100%, is 106U4.8% (except cells labeled
control). Throughout the ¢gure the EGFr is marked with an arrow.
B: Time course: The A431 cells were incubated with or without
K-HL (60 nM)) for indicated time periods followed by stimulation
with TGFK and the rest of the experiment is done as described
above. The mean density of all EGFr bands present in the bottom
panel by taking the TGFK stimulated lane as 100% is 106U 13%.
C: Absence of phosphorylation of EGFr dimers: A431 cells were
treated with K-HL (0.6 WM) followed by stimulation with TGFK.
Cross-linking was initiated with glutaraldehyde as described in Sec-
tion 2. The blot was probed with anti-EGFr antibody (sheep poly-
clonal) (left) and 6G9 anti-phosphotyrosine antibody (right) as de-
scribed above.
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(nucleated vs. red blood cells) [11]. The depletion of cellular
ATP pool is an unlikely reason for the observed e¡ects in the
current experiments for the following reasons: (i) The lag
period for K-HL(5^293) is several folds higher than that of
wild type K-HL. Thus the membrane damage induced by
K-HL(5^293) is insigni¢cant in the time frame of the observed
diminished phosphorylation [11]. (ii) Membrane damage is
also excluded by our observation that the A431 cells treated
with K-HL and K-HL(5^293) at 60 nM concentration do not
take up trypan blue for 2 h (less than 1% of cells were
stained). This clearly indicates that noticeable membrane
damage (due to lytic pore formation) had not occurred during
the time frame of diminished phosphorylation. (iii) Identical
results were obtained, when exogenous ATP was added to the
A431 cells during the K-HL treatment (note that the pore of
K-HL is mostly non-selective and bi-directional). (iv) Direct
measurement of the amount of ATP leakage due to the pres-
ence of K-HL or K-HL(5^293) evoked only marginal loss
(about V10^14%) in the time frame of the diminished phos-
phorylation observed (Fig. 3C). All these observations
strongly support our hypothesis that the observed loss of
phosphorylation at the EGFr is not due to the depletion of
intracellular ATP pool.
The possibility of down regulation of EGFr occurring with-
in 2^15 min is highly unlikely as the down regulation of EGFr
in A431 cells occurs in about 4^6 h, according to Krupp and
co-workers [18] and Sturani and co-workers [19]. Shedding of
EGFr could be excluded based on our experiments which
showed a complete absence of additional low molecular
weight fragments of EGFr (data not shown) in the toxin
treated cells. This is in sharp contrast to the shedding of IL-
6 receptors induced by the treatment of streptolysin O, anoth-
er pore forming toxin. It is noteworthy to mention here that
the shedding of IL-6 was not induced by a streptolysin O
mutant that retained cell binding ability but lacked pore form-
ing activity [20]. Our data in conjunction with the streptolysin
O data clearly implies that both K-HL and K-HL(5^293) do
not a¡ect the integrity of EGFr. In addition, the possibility of
membrane bound monomers associating with EGFr through
various interactions is also ruled out because treatment of
A431 cells with H35N did not result in the diminished phos-
phorylation of EGFr (Fig. 4A). All these observations point
out to the possibility that K-HL indirectly in£uences the EGFr
phosphorylation and the assembly of K-HL is crucial for this
e¡ect.
Among several possibilities, the situation presented here is
somewhat reminiscent of an earlier observation by Sturani et
al. [18]. These authors subjected the EGF stimulated A431
cells to acid wash in order to remove the bound ligand and
found that the degree of phosphorylation of the EGFr de-
creased with time. It is possible in our experiments that it is
the phosphorylated EGFr that is a¡ected by K-HL. Hence, it
is logical to suspect the involvement of an active PTPase. This
is very well in line with the current knowledge on the dynamic
control of many signaling cascades by kinases and PTPases
associated either with the cell surface or present in the cyto-
plasm [22,23].
Experiments were carried out in the presence of phospha-
tase inhibitors in order to examine the role of PTPases in
detail. The data presented in Fig. 4B clearly shows that in
the presence of sodium orthovanadate the dephosphorylation
of EGFr induced by K-HL was greatly reduced or retarded.
The reduction in the dephosphorylation induced by K-HL is
striking only when the sodium orthovanadate treatment pre-
cedes the K-HL treatment, i.e. when cells were ¢rst stimulated
with TGFK followed by sodium orthovanadate treatment or
vice versa. From Fig. 4B (iv), it is also clear that when the
cells were treated with the K-HL prior to the treatment with
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Fig. 3. A: Time dependence of diminished phosphorylation of EGF
receptor induced by K-HL(5^293): A431 cells were incubated with
or without K-HL(5^293) (60 nM) for di¡erent time periods and the
rest of the experiment was done as described earlier. The phosphor-
ylation and anti-EGFr patterns were obtained as Fig. 2. The mean
density of all EGFr bands present in the bottom panel by consider-
ing the TGFK stimulated lane as 100% is 113U9.5%. B: Compari-
son of kinetics of EGFr dephosphorylation by K-HL and K-HL(5^
293): The intensity of phosphorylation signals shown in Figs. 2B
and 3A were quanti¢ed by densitometric scanning and plotted
against time. C: Determination of ATP leakage due to pore forma-
tion: The ATP released due to the binding of K-HL was assayed by
ATP Bioluminescence kit from Bo‹ehringer-Mannheim. The experi-
ment was carried out as described in Section 2. The data represents
the average observations of two di¡erent individuals using the same
batch of cells at the same time.
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sodium orthovanadate, no reduction in the e¡ect of K-HL was
seen. We also examined whether prestimulated receptors can
loose their existing phosphorylation signal in the presence of
K-HL by using TGFK stimulated A431 cells. Fig. 5A,B shows
that there is a dramatic loss of existing phosphorylation of
EGFr with time. If prestimulated cells are treated with K-HL
followed by treatment with sodium orthovanadate, then the
e¡ect of K-HL is only retarded (as seen in Fig. 5A,B; unpub-
lished observations). However, this observation needs to be
deciphered further as the e¡ect of K-HL on prestimulated cells
is comparatively slow (Fig. 2B vs. Fig. 5B). Interestingly,
H35N, a mutant form of K-HL devoid of complete assembly,
does not in£uence the dephosphorylation of EGFr (Fig. 4A).
Moreover, this phenomenon of dephosphorylation of EGFr
by K-HL occurs in other carcinoma cell lines as well, since the
EGFr present in KB (squamous carcinoma, ATCC CCL 17)
cell line also did not retain its phosphorylation signal (Fig.
5C). As per the current knowledge, a phosphorylated receptor
is dephosphorylated only with the assistance of a PTPase.
A
1 2 3 4 5B
U S α-HL 0.6 1.2 1.8 3.0
U S 15 30 60 90 120
H35N
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(i)
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(iv)
Fig. 4. A: E¡ect of H35N on EGFr phosphorylation: Concentra-
tion dependence (top): The A431 cells were treated with H35N and
processed as described above. U, S and K-HL denote unstimulated,
TGFK stimulated and K-HL (60 nM) treated A431, cells respec-
tively. The mean density of all the EGFr bands visualized by
PY20^HRP by taking the TGFK stimulated lane as 100% is
113U 13.5% (the K-HL lane has 7% signal). Time dependence (bot-
tom): The A431 cells were incubated with 1.8 WM H35N for di¡er-
ent time periods and the experiment was carried out as described
above. The mean density of all the EGFr bands visualized by
PY20^HRP (bottom panel) by taking the TGFK stimulated lane as
100% is 92U 6.4%. The corresponding anti-EGFr antibody blots
showed similar intensities of EGFr with anti-EGFr antibody SC-03
(data not shown). B: E¡ect of K-HL on EGFr phosphorylation in
the presence of the phosphatase inhibitor sodium orthovanadate:
Cells were incubated at 37‡C for 30 min in the absence (i) and pres-
ence (ii) of 1 mM orthovanadate and treated with K-HL followed
by stimulation with TGFK for 10 min. The mean density of all the
phosphotyrosine bands present in panel B by taking the TGFK
stimulated band as 100% is 103U8.9%. (iii) Cells were incubated
with 100 mM sodium orthovanadate, stimulated with TGFK fol-
lowed by treatment with K-HL. Note that lane 5 had less phosphor-
ylation signal for unknown reasons or probably due to cell loss as a
result of high concentration of sodium orthovanadate coupled with
high concentrations of K-HL and longer incubation times. (iv) Cells
were ¢rst incubated with K-HL, then treated with 1 mM Na3VO4
followed by stimulation with TGFK. In all four panels, lane 1: un-
stimulated A431 cells; lane 2: TGFK stimulated cells ; lanes 3^5:
cells treated for 60 min with 50 nM, 100 nM and 200 nM KHL re-
spectively. The phosphorylation pattern was identi¢ed by PY20^
HRP and the corresponding anti-EGFr blots showed similar inten-
sities of EGFr with anti-EGFr SC-03 (data not shown).
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Fig. 5. A,B: Reversal of EGFr tyrosine phosphorylation by K-HL:
A431 cells (1.5U105) were pretreated with TGFK (70 nM) for 5 min
at 37‡C. One set was incubated further without addition of tox-
in (‘3’ lanes 2^5, panels A and B) and the other set (‘+’ lanes 6^9,
panels A and B) was incubated at 37‡C for indicated periods of
time. after addition of K-HL (100 nM). For panel A, TGFK was re-
moved before addition of K-HL(100 nM) (lanes 6^9). The mean
density of all the EGFr bands present in the bottom panel by tak-
ing the TGFK stimulated lane as 100% is 98U 9.8%. Lanes 6^9 have
104%, 94%, 49% and 25% phosphorylation signal to that of the re-
spective intensities present in lanes 2^4. For panel B lanes 6^9
K-HL (100 nM) was added without removing TGFK. Lane 1 (A and
B) shows control cells (U) incubated at 37‡C for 15 min. Lanes 6^9
have 98%, 94%, 70% and 18% phosphorylation signal to that of the
respective intensities present in lanes 2^4. The mean density of all
the EGFr bands present in the bottom panel by taking the TGFK
stimulated lane as 100% is 96U5.4%. The phosphorylation pattern
was obtained by PY20^HRP and the EGFr band was detected by
SC-03 anti-EGFr antibody. C: E¡ect of K-HL on phosphorylation
of the EGFr on KB cells: The experiment with KB cells is done as
with the A431 cells described in Fig. 2. Lane 1: A431 cells alone;
lane 2: A431 cells stimulated with TGFK for 10 min; lanes 3^9 the
toxin concentrations are 1 nM, 5 nM, 25 nM, 50 nM, 100 nM, 200
nM, 500 nM respectively. The phosphorylation and EGFr patterns
were obtained as described above. The mean density of all the
EGFr bands present in the bottom panel by taking the TGFK
stimulated lane as 100% is 96U5.5%.
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Collectively, our data strongly suggests that the e¡ect of K-HL
is mediated via a PTPase and is dependent on the oligomeri-
zation property of the toxin. One likely mechanism for the
observed loss of phosphorylation at EGFr is that immediately
after binding, the K-HL engages or activates a PTPase (for-
mation of a molecular ensemble) which may shift the equilib-
rium of net phosphorylation^dephosphorylation reactions oc-
curring at the EGFr towards dephosphorylation.
Our attempts to identify the PTPase involved were so far
unsuccessful, probably due to the extremely low level of ex-
pression in vivo. This observation is consistent with the data
reported by Pestana and colleagues. These authors could not
detect the endogenous rPTPc in immunoprecipitation and
subsequent immunoblotting approaches [24]. In another in-
stance, Tiganis and colleagues had to overexpress the T cell
PTPase to detect its cellular target [25,26]. However, in the
present context it is absolutely necessary for us to work under
the endogenous concentrations rather than with cells lines that
overexpress di¡erent PTPases. In view of these di⁄culties it is
necessary to design alternate methods to identify, at endoge-
nous concentrations, the PTPase involved in the present con-
text and such attempts are currently underway.
In summary, the data presented here will invoke further
interest in understanding the pathogenesis of S. aureus in
humans in general and in particular the interaction of K-HL
and/or similar proteins with certain membrane components
present on mammalian cells and their ability to regulate the
signal transduction cascades.
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